PREliminary Safety Evaluation of Nanoporous Tacrolimus eluting stents - PRESENT


Trial designed to test a tracrolimus-eluting stent in coronary arteries.

Study Design

Study Design:

Patients Enrolled: 60

Primary Endpoints:

Death, MI, TVR

Drug/Procedures Used:

30 patients received a ceramic-coated stent and 30 received a ceramic-coated stent including 60 mcg tacrolimus. Follow-up is scheduled at 14 days, 6 months, and 12 months.

Principal Findings:

Two patients receiving the drug-coated stent experienced adverse coronary events (unstable angina), one after 67 days and a second after 59 days.


Final results are pending as are angiographic and late clinical follow-up.

Clinical Topics: Invasive Cardiovascular Angiography and Intervention, Stable Ischemic Heart Disease, Chronic Angina

Keywords: Follow-Up Studies, Ceramics, Coronary Restenosis, Drug-Eluting Stents, Coronary Vessels, Sirolimus, Tacrolimus

< Back to Listings